Zinc induces dendritic cell tolerogenic phenotype and skews regulatory T Cell-Th17 balance

Journal of Immunology

Volumn 197, Issue 5, 2016, Pages 1864-1876

  George, Mariam Mathew ^a   Vignesh, Kavitha Subramanian ^b   Landero Figueroa, Julio A ^c   Caruso, Joseph A ^c   Deepe, George S ^b,d  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; BETA INTERFERON; CD103 ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; KYNURENINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRYPTOPHAN; TUMOR NECROSIS FACTOR; ZINC SULFATE; PDCD1LG2 PROTEIN, MOUSE; ZINC;

AJELLOMYCES CAPSULATUS; AMINO ACID SYNTHESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; DRUG DETERMINATION; DRUG MECHANISM; GENE EXPRESSION REGULATION; HISTOPLASMOSIS; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MINERAL SUPPLEMENTATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH17 CELL; UPREGULATION; ANIMAL; BONE MARROW CELL; DRUG EFFECTS; GENE; GENETICS; HISTOPLASMA; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE MARROW CELLS; DENDRITIC CELLS; GENES, MHC CLASS II; HISTOPLASMA; HISTOPLASMOSIS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; LYMPHOCYTE ACTIVATION; MICE; PHENOTYPE; PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRYPTOPHAN; ZINC;

EID: 84983739154     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600410     Document Type: Article

References (52)

1. Shortman, K., and S. H. Naik. 2007. Steady-state and inflammatory dendriticcell development. Nat. Rev. Immunol. 7: 19-30.
2. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
3. Prasad, A. S. 1998. Zinc and immunity. Mol. Cell. Biochem. 188: 63-69.
4. Hirano, T., M. Murakami, T. Fukada, K. Nishida, S. Yamasaki, and T. Suzuki. 2008. Roles of zinc and zinc signaling in immunity: zinc as an intracellular signaling molecule. Adv. Immunol. 97: 149-176.
5. Prasad, A. S. 2000. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J. Infect. Dis. 182(Suppl. 1): S62-S68.
6. Bao, S., M. J. Liu, B. Lee, B. Besecker, J. P. Lai, D. C. Guttridge, and D. L. Knoell. 2010. Zinc modulates the innate immune response in vivo to polymicrobial sepsis through regulation of NF-kB. Am. J. Physiol. Lung Cell. Mol. Physiol. 298: L744-L754.
7. Stafford, S. L., N. J. Bokil, M. E. Achard, R. Kapetanovic, M. A. Schembri, A. G. McEwan, and M. J. Sweet. 2013. Metal ions in macrophage antimicrobial pathways: emerging roles for zinc and copper. Biosci. Rep. 33: e00049.
8. Tan, J. K., and H. C. O'Neill. 2005. Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity. J. Leukoc. Biol. 78: 319-324.
9. Kitamura, H., H. Morikawa, H. Kamon, M. Iguchi, S. Hojyo, T. Fukada, S. Yamashita, T. Kaisho, S. Akira, M. Murakami, and T. Hirano. 2006. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat. Immunol. 7: 971-977.
10. Maldonado, R. A., and U. H. von Andrian. 2010. How tolerogenic dendritic cells induce regulatory T cells. Adv. Immunol. 108: 111-165.
11. Liang, L., andW. C. Sha. 2002. The right place at the right time: novel B7 family members regulate effector T cell responses. Curr. Opin. Immunol. 14: 384-390.
12. Mellor, A. 2005. Indoleamine 2,3 dioxygenase and regulation of T cell immunity. Biochem. Biophys. Res. Commun. 338: 20-24.
13. Kauffman, C. A., K. S. Israel, J. W. Smith, A. C. White, J. Schwarz, and G. F. Brooks. 1978. Histoplasmosis in immunosuppressed patients. Am. J. Med. 64: 923-932.
14. Gildea, L. A., R. E. Morris, and S. L. Newman. 2001. Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells. J. Immunol. 166: 1049-1056.
15. Widner, B., E. R. Werner, H. Schennach, H. Wachter, and D. Fuchs. 1997. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin. Chem. 43: 2424-2426.
16. Kilshaw, P. J. 1993. Expression of the mucosal T cell integrin a M290 b 7 by a major subpopulation of dendritic cells in mice. Eur. J. Immunol. 23: 3365-3368.
17. Coombes, J. L., K. R. Siddiqui, C. V. Arancibia-Cárcamo, J. Hall, C. M. Sun, Y. Belkaid, and F. Powrie. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204: 1757-1764.
18. Asano, N., T. Watanabe, A. Kitani, I. J. Fuss, and W. Strober. 2008. Notch1 signaling and regulatory T cell function. J. Immunol. 180: 2796-2804.
19. Yan, Y., G. X. Zhang, B. Gran, F. Fallarino, S. Yu, H. Li, M. L. Cullimore, A. Rostami, and H. Xu. 2010. IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J. Immunol. 185: 5953-5961.
20. Orabona, C., P. Puccetti, C. Vacca, S. Bicciato, A. Luchini, F. Fallarino, R. Bianchi, E. Velardi, K. Perruccio, A. Velardi, et al. 2006. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 107: 2846-2854.
21. Jansen, M., and J. F. Reinhard, Jr. 1999. Interferon response heterogeneity: activation of a pro-inflammatory response by interferon a and b: a possible basis for diverse responses to interferon b in MS. J. Leukoc. Biol. 65: 439-443.
22. Hassanain, H. H., S. Y. Chon, and S. L. Gupta. 1993. Differential regulation of human indoleamine 2,3-dioxygenase gene expression by interferons-g and-a: analysis of the regulatory region of the gene and identification of an interferong?inducible DNA-binding factor. J. Biol. Chem. 268: 5077-5084.
23. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1? and IL-18?mediated function. Immunity 9: 143-150.
24. Chua, J. S., A. M. Rofe, and P. Coyle. 2006. Dietary zinc supplementation ameliorates LPS-induced teratogenicity in mice. Pediatr. Res. 59: 355-358.
25. Wong, C. P., Y. Song, V. D. Elias, K. R. Magnusson, and E. Ho. 2009. Zinc supplementation increases zinc status and thymopoiesis in aged mice. J. Nutr. 139: 1393-1397.
26. Sun, C. M., J. A. Hall, R. B. Blank, N. Bouladoux, M. Oukka, J. R. Mora, and Y. Belkaid. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204: 1775-1785.
27. Liu, C., C. J. Workman, and D. A. Vignali. Targeting regulatory T cells in tumors. FEBS J. In press.
28. + T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10: 29-37.
29. Lázár-Molnár, E., A. Gácser, G. J. Freeman, S. C. Almo, S. G. Nathenson, and J. D. Nosanchuk. 2008. The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum. Proc. Natl. Acad. Sci. USA 105: 2658-2663.
30. Salama, A. D., T. Chitnis, J. Imitola, M. J. Ansari, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury. 2003. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. [Published erratum appears in 2003 J. Exp. Med. 198: 677.] J. Exp. Med. 198: 71-78.
31. Terness, P., T. M. Bauer, L. Röse, C. Dufter, A.Watzlik, H. Simon, and G. Opelz. 2002. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenaseexpressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196: 447-457.
32. Tailor, P., T. Tamura, H. J. Kong, T. Kubota, M. Kubota, P. Borghi, L. Gabriele, and K. Ozato. 2007. The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 27: 228-239.
33. Brieger, A., L. Rink, and H. Haase. 2013. Differential regulation of TLRdependent MyD88 and TRIF signaling pathways by free zinc ions. J. Immunol. 191: 1808-1817.
34. Horng, T., G. M. Barton, R. A. Flavell, and R. Medzhitov. 2002. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420: 329-333.
35. Yamamoto, M., S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira. 2002. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-b promoter in the Toll-like receptor signaling. J. Immunol. 169: 6668-6672.
36. Uzzo, R. G., P. L. Crispen, K. Golovine, P. Makhov, E. M. Horwitz, and V. M. Kolenko. 2006. Diverse effects of zinc on NF-kB and AP-1 transcription factors: implications for prostate cancer progression. Carcinogenesis 27: 1980-1990.
37. Tucci, M., S. Stucci, S. Strippoli, and F. Silvestris. 2010. Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus. J. Biomed. Biotechnol. 2010: 457146.
38. Knoell, D. L., M. W. Julian, S. Bao, B. Besecker, J. E. Macre, G. D. Leikauf, R. A. DiSilvestro, and E. D. Crouser. 2009. Zinc deficiency increases organ damage and mortality in a murine model of polymicrobial sepsis. Crit. Care Med. 37: 1380-1388.
39. Gaetke, L. M., C. J. McClain, R. T. Talwalkar, and S. I. Shedlofsky. 1997. Effects of endotoxin on zinc metabolism in human volunteers. Am. J. Physiol. 272: E952-E956.
40. Pollara, G., M. E. Handley, A. Kwan, B. M. Chain, and D. R. Katz. 2006. Autocrine type I interferon amplifies dendritic cell responses to lipopolysaccharide via the nuclear factor-kB/p38 pathways. Scand. J. Immunol. 63: 151-154.
41. Chang, J., S. Thangamani, M. H. Kim, B. Ulrich, S. M. Morris, Jr., and C. H. Kim. 2013. Retinoic acid promotes the development of Arg1-expressing dendritic cells for the regulation of T-cell differentiation. Eur. J. Immunol. 43: 967-978.
42. Bhatt, S., J. Qin, C. Bennett, S. Qian, J. J. Fung, T. A. Hamilton, and L. Lu. 2014. All-trans retinoic acid induces arginase-1 and inducible nitric oxide synthaseproducing dendritic cells with T cell inhibitory function. J. Immunol. 192: 5098-5108.
43. Rosenkranz, E., C. H. Metz, M. Maywald, R. D. Hilgers, I. Wessels, T. Senff, H. Haase, M. Jager, M. Ott, R. Aspinall, et al. 2015. Zinc supplementation induces regulatory T cells by inhibition of Sirt-1 deacetylase in mixed lymphocyte cultures. Mol. Nutr. Food Res. 60: 661-671.
44. Kitabayashi, C., T. Fukada, M. Kanamoto, W. Ohashi, S. Hojyo, T. Atsumi, N. Ueda, I. Azuma, H. Hirota, M. Murakami, and T. Hirano. 2010. Zinc suppresses Th17 development via inhibition of STAT3 activation. Int. Immunol. 22: 375-386.
45. Rosenkranz, E., R. D. Hilgers, P. Uciechowski, A. Petersen, B. Plumäkers, and L. Rink. Zinc enhances the number of regulatory T cells in allergen-stimulated cells from atopic subjects. Eur. J. Nutr. In press.
46. Lock, C., G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, et al. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8: 500-508.
47. Lubberts, E. 2003. The role of IL-17 and family members in the pathogenesis of arthritis. Curr. Opin. Investig. Drugs 4: 572-577.
48. Allendoerfer, R., and G. S. Deepe, Jr. 1997. Intrapulmonary response to Histoplasma capsulatum in g interferon knockout mice. Infect. Immun. 65: 2564-2569.
49. Kroetz, D. N., and G. S. Deepe, Jr. 2010. CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infection. J. Immunol. 184: 5224-5231.
50. +CD25+ T cells that inhibit protective immunity in murine histoplasmosis. J. Immunol. 180: 1088-1097.
51. Subramanian Vignesh, K., J. A. Landero Figueroa, A. Porollo, J. A. Caruso, and G. S. Deepe, Jr. 2013. Granulocyte macrophage-colony stimulating factor induced Zn sequestration enhances macrophage superoxide and limits intracellular pathogen survival. Immunity 39: 697-710.
52. Subramanian Vignesh, K., J. A. Landero Figueroa, A. Porollo, J. A. Caruso, and G. S. Deepe, Jr. 2013. Zinc sequestration: arming phagocyte defense against fungal attack. PLoS Pathog. 9: e1003815.